35H Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Homology Medicines Inc

Watchlist Manager

Watchlist

Price: 14.94 EUR 1 700% Market Closed

Market Cap: €751m

H	Homology Medicines Inc F:35H	US
	Xos Inc F:9KR0	US
	Sterling Construction Company Inc NASDAQ:STRL	US
B	Brookdale Senior Living Inc F:B7S	US
	Essential Properties Realty Trust Inc F:2OU	US

Profitability Summary

Homology Medicines Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Exceptional Operating Margin

31%

Negative 3Y Average Operating Margin

-8 283%

Operating Margin is Increasing

-3 849% > 31%

Exceptional Net Margin

55%

Negative 3Y Average Net Margin

-8 995%

Net Margin is Increasing

-3 936% > 55%

Negative Free Cash Flow Margin

-62%

Negative 3Y Average Free Cash Flow Margin

-8 338%

Free Cash Flow Margin is Increasing

-3 419% > -62%

Exceptional ROE

125%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-392%

ROIC is Increasing

-276% > 141%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.